Rheumaderm pp 193-199 | Cite as

Dermatomyositis Associated with Malignancy

12 Case Reports
  • Lyubomir A. Dourmishev
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)


Dermatomyositis (DM) is an idiopathic inflammatory disease of unknown etiology which manifests itself with symmetrical proximal muscle weakness and typical heliotrope skin rash. Internal malignancy is a specific trigger for some cases of DM. The aim of this study is to find predictive signs of cancer in dermatomyositis patients. Twelve (2 males and 10 females) (24%) out of 50 adult patients with DM(10 males and 40 females between 21 and 81 years old) had associated with malignancy (paraneopastic dermatomyositis, PDM). The male: female ratio in patients with idiopathic dermatomyositis (IDM) was 1:3.75 and for PDM it was 1:5. The frequency of dermatomyositis increases with age. PDM is most frequent between 40 and 69 years of life. Associated malignancies were respiratory tract carcinomas in males, genital and breast carcinomas in females. DM preceded the carcinoma in 5 cases (41,7%); 7 patients (58.3%) had already been treated for malignancy. In conclusion PDM in our country is more frequent in females and in the age after 40 years. Association of dermatomyositis with malignancy is relatively high.


Ovarian Cancer Inclusion Body Myositis Internal Malignancy Amyopathic Dermatomyositis Early Ovarian Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Al Ballaa S., Al Dalaan A., El Ramahi K. Pattern of adult onset of polymyositis and dermatomyositis and association with malignancy. Ann. Saudi. Med. 13/6, 525–9 (1993).Google Scholar
  2. 2.
    Basset-Seguin N., Roujeau J., Gherardi R. et al. Prognostic factors and predicative signs of malignanci in adult dermatomyositis. Arch. Dermatol. 126: 633–37 (1990).PubMedCrossRefGoogle Scholar
  3. 3.
    Bernard P., Bennethblanc J. Dermatomyositis and malignancy. J. Invest. Dermatol., 100, 1, 128S–132S (1993).PubMedCrossRefGoogle Scholar
  4. 4.
    Bohan A, Peter J.B. Polymyositis and dermatomyositis. N. Engl. J. Med. 292, 345–7 (1975).Google Scholar
  5. 5.
    Bonnetblanc J., Bernard P., Fayol J. Dermatomyositis and malignancy: a multicenter cooperative study. Dermatologica, 180: 212–216(1990).PubMedCrossRefGoogle Scholar
  6. 6.
    Cherin P. et al. Dermatomyositis and ovarian cancer: a report of 7 cases and literature. J. Rheumatol., 20, 11, 1897–9(1993).PubMedGoogle Scholar
  7. 7.
    Cox NH et al. Dermatomyositis; disease association and an evaluation of screening investigations for malignancy. Arch. Dermatol., 126, 61 (1990).PubMedCrossRefGoogle Scholar
  8. 8.
    Davis M, Ahmed I. Ovarian malignancy in patients with dermatomyositis and polymyositis: a retrospective analysis of fourteen cases. J. Am. Acad. Dermatol., 37: 730–733 (1997).PubMedCrossRefGoogle Scholar
  9. 9.
    Duncan H., Richardson J., Klein J. et al. Clinical, serologic, and immunogenic study in patients with dermatomyositis. Acta Dermato.Venereol., 71: 312–16 (1991).Google Scholar
  10. 10.
    Euwer R., Sontheimer R., Amyopathic dermatomyositis: a review. J. Invest. Dermatol., 100, 124S–128S (1993).PubMedCrossRefGoogle Scholar
  11. 11.
    Hidano A., Torikai S. Uemura T. et al. Malignancy and intestitial pulmonitis as fatal complication in dermatomyositis. J. Dermatol., 19: 153–160 (1992).PubMedGoogle Scholar
  12. 12.
    Holmes C, Massa M. Skin signs of systemic diseases — When the problem is more than skin-deep. Postgrad Med. 96 8, 93–100(1994).PubMedGoogle Scholar
  13. 13.
    Koh E., Seow A., Ong B. et al. Adult onset polymyositis/dermatornyositis: clinical and laboratory features and treatment response in 75 patients. Ann. Rheum. Dis., 52: 857–61 (1993).PubMedCrossRefGoogle Scholar
  14. 14.
    Kankeleit — Uber primaire nichteitrige polymyositis. Dtsch. Arch. Klin. Med., 120. 335–9 (1916).Google Scholar
  15. 15.
    Lifermann F., Brucher C, Coquet M. et al. Dermatomyosite de l’adulte et cancer: 25 observations. Rev. Med. Int., 14: 492–6(1993).CrossRefGoogle Scholar
  16. 16.
    Manchul L. et al. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. Arch.Int.Med., 145, 1835–9(1985).CrossRefGoogle Scholar
  17. 17.
    Rose C. et al. Signes predicatifs of de cancers au cours de la dermatomyosite. Etude de 29 observations. Rev. Med. Int., 15, 1, 19–24 (1994).CrossRefGoogle Scholar
  18. 18.
    Stertz G. Polymyositis. Berl. Klin. Wochenshr., 53, 489 (1916).Google Scholar
  19. 19.
    Tanimoto K, Nakano K, Kano S. et al. Gasification criteria for polymyositis and dermatomyositis. J. Rhematol., 22: 4, 668–674 (1995).Google Scholar
  20. 20.
    Whitmore S., Rosenshein N., Provost T., Ovarian cancer in patients with dermatomyositis. Medicine., 73, 3, 153–60 (1994).PubMedCrossRefGoogle Scholar
  21. 21.
    Whitmore S., Anhalt G., Provost T.,-et al. Serum CA-125 screening for ovarian cancer in patients with dermatomyositis. Gynecol Oncol., 65: 241–4 (1997).PubMedCrossRefGoogle Scholar
  22. 22.
    Whitmore S., Watson R. et al. Dermatomyositis sine myositis: Association with malignancy. J. Rhematol., 23, 101–5(1996).Google Scholar
  23. 23.
    Zantos D., Zhang Y., Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J. Rhematol., 21: 1855–59 (1994).Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Lyubomir A. Dourmishev
    • 1
  1. 1.Department of DermatologyMedical UniversitySofiaBulgaria

Personalised recommendations